Tetanus is a noncommunicable infectious disease of humans and certain animal species, acquired usually through environmental exposure. Clostridium tetani is an anaerobic, spore-forming bacilli ubiquitous in the soil. The spores germinate to vegetative bacilli when introduced into the soft tissues of the host under conditions in which the partial pressure of molecular oxygen is low. The vegetative organisms produce a potent neurotoxin that acts on the central nervous system (CNS), leading to the muscular contractions characteristic of the illness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carle, A., and Rattone, G., Studio sperimentale sull’ etiologia del tetano, G. Accad. Med. Torino 32:174 (1884).
Nicolaier, A., Über infectiösen Tetanus, Dtsch. Med. Wochenschr. 10:842–844 (1884).
Rosenbach. Zur Ätiologie des Wundstarrkrampfes beim Menschen, Arch. Klin. Chir. 34:306–317 (1886).
Kitasato, S., Ueber den Tetanusbacillus, Z. Hyg. 7:225–234 (1889).
Von Behring, E., and Kitasato, S., Über das Zustandekommen der Diphtherie-Immunität und Tetanus-Immunität bei Thieren, Dtsch. Med. Wochenschr. 16:1113–1114 (1890).
Descombey, P., L’anatoxine tetanique, Can. R. Soc. Biol. 91:239–241 (1924).
Kircher, T., and Anderson, R. E., Cause of death: Proper completion of the death certificate, J. Am. Med. Assoc. 77:137–139 (1987).
Galazka, A., Birmingham, M., Kurian, M., and Gasse, F., Tetanus. In: Murray, C. J. L., Lopez, A. D., and Mathers, C. D. (eds.). The Global Epidemiology of Infectious Diseases [electronic resource]. Geneva, World Health Organization, pp. 151–199, 2004. Available at http://whqlibdoc.who.int/publications/2004/9241592303_chap6.pdf
Stanfield, J. P., and Galazka, A., Neonatal tetanus in the world today, Bull. WHO 62:647–669 (1984).
Quddus, A., Luby, S., Rahbar, M., Pervaiz Y., Neonatal tetanus: Mortality rate and risk factors in Loralai District, Pakistan, Int. J. Epidemiol. 31:648–653 (2002).
Brauner, J. S., Rios Vieira, S. R., and Bleck, T. P., Changes in severe accidental tetanus mortality in the ICU during two decades in Brazil, Intensive Care Med. 28:930–935 (2002).
Cook, T. M., Protheroe, R. T., and Handel, J. M., Tetanus: A review of the literature, Br. J. Anaesth. 87:477–487 (2001).
Thwaites, C. L., Yen, L. M., Nga, N. T., et al., Impact of improved vaccination programme and intensive care facilities on incidence and outcome of tetanus in southern Vietnam, 1993–2002, Trans. R. Soc. Trop. Med. Hyg. 98:671–677 (2004).
Saltigeral, S. P., Macias, P. M., Mejia, V. J., Sosa, V. M., Castilla, S. L., and Gonzalez, S. N. Neonatal tetanus experience at the National Institute of Pediatrics in Mexico City, Pediatr. Infect. Dis. J. 12:722–725 (1993).
Sutter, R. W., Cochi, S. L., Brink, E. W., and Sirotkin, B. I., Assessment of vital statistics and surveillance data for monitoring tetanus mortality, 1979–1984, Am. J. Epidemiol. 131:132–142 (1990).
MacLennan, R., Schofield, F. D., Pittman, M., Hardegree, M. C., and Banile, M. F., Immunization against neonatal tetanus in New Guinea: Antitoxin response of pregnant women to adjuvant and plain toxoids, Bull. WHO 32:683–697 (1965).
Newell K. W., LeBlank, D. R., Edsall, G., et al., The serological assessment of a tetanus toxoid field trial, Bull. WHO 45:773–785 (1971).
McComb, J. A., The prophylactic dose of homologous tetanus antitoxin, N. Engl. J. Med. 270:175–178 (1964).
Cain, H. D., and Falco, F. G., Recurrent tetanus, Calif. Med. 97:31–33 (1962).
Spenney, J. G., Lamb, R. N., and Cobbs, C. G., Recurrent tetanus, South. Med. J. 64:859–862 (1971).
Bhatt, A. D., and Dastur, F. D., Relapsing tetanus: A case report, J. Postgrad. Med. 27:184–186 (1981).
Gergen, P. J., McQuillan, G. M., Kiely, M., Ezzati-Rice, T. M., Sutter, R. W., and Virella, G., A population-based serologic survey of immunity to tetanus in the United States, N. Engl. J. Med. 332: 761–766 (1995).
Barile, M. F., Hardegree, M. C., and Pittman, M., Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea pigs to the toxoids as used in the immunization schedules in New Guinea, Bull. WHO 43:453–459 (1970).
Melville-Smith, M. E., Seagroatt, V. A., and Watkins, J. T., A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera, J. Biol. Stand. 11:137–144 (1983).
Virella, G., and Hyman, B., Quantification of anti-tetanus and anti-diphtheria antibodies by enzymoimmunoassay: Methodology and applications, J. Clin. Lab. Anal. 5:43–48 (1991).
Pitzurra, L. F., Bistoni, M., Pitzurra, L., et al., Comparison of passive haemagglutination with turkey erythrocyte assay, enzyme-linked immunosorbent assay and counter-immunoelectrophoresis assay for serological evaluation of tetanus immunity, J. Clin. Microbiol. 17:432–435 (1983).
Borrow, R., Balmer, P., and Roper M. H., Immunological basis for immunization series; module 3: Tetanus update 2006. Geneva, World Health Organization, 2007. Available at: http://www.who.int/vaccines-documents/DocsPDF07/869.pdf.
Ourth, D. D., and MacDonald, A. B., Neutralization of tetanus toxin by human and rabbit immunoglobulin classes and subunits, Immunology 3:807–815 (1977).
Hatheway, C. L., and Johnson, E. A. Clostridium: The spore-bearing anaerobes. In Collier, L., Balows, A., and Sussman, M. (eds.). Topley & Wilson’s Microbiology and Microbial Infections (9th ed, Vol. 2). Arnold, London, pp. 731–782, 1998.
Turner, T. B., Velasco-Joven, E. A., and Prudovsky, S., Studies on the prophylaxis and treatment of tetanus. II. Studies pertaining to treatment, Bull. Johns Hopkins Hosp. 102:71–84 (1958).
Passen, E. L., and Andersen, B. R., Clinical tetanus despite a “protective” level of toxin-neutralizing antibody, J. Am. Med. Assoc. 255:1171–1173 (1986).
Finn, L. W., Silver, R. P., Habig, W. H., and Hardegree, M. C., The structural gene for tetanus neurotoxin is on a plasmid, Science 224:881–884 (1984).
Matsuda, M., and Yoneda, M., Isolation and purification of two antigenically active, “complementary” polypeptide fragments of tetanus neurotoxin, Infect. Immun. 12:1147–1153 (1975).
Wright, G. P., The neurotoxins of Clostridium botulinum and Clostridium tetani, Pharmacol. Rev. 7:413–456 (1955).
Pellizzari, R., Roesstto, O., Schiavo, G., and Monteccucco, C., Tetanus and botulinum neurotoxins: Mechanism of action and therapeutic uses, Philos. Trans. R. Soc. Lond. 354:259–268 (1999).
Bytchenko, B. D., Causse, G., Grab, B., and Kereselidze, T. S., Tetanus: Recent trends of world distribution. In Merieux, C. (ed.). Sixth International Conference on Tetanus. Lyon, Collection Foundation Merieux, pp. 97–111, 1981.
Fauveau, V., Mamdani, M., Steinglass, R., and Koblinsky, M., Maternal tetanus: Magnitude, epidemiology and potential control measures, Int. J. Gynecol. Obstet. 40:3–12 (1993).
Rey, M., and Tikhomirov, E., Non neonatal tetanus over the world. In Nistico, G., Bizzini, B., Bytchenko, M., and Triau, R. (eds.). Proceedings of the Eighth International Conference on Tetanus, Leningrad, USSR, August 25–28, 1987. Pythagora Press, Rome, pp. 506– 518, 1989.
World Health Organization, Expanded Programme on Immunization—progress towards the elimination of neonatal tetanus, 1989–1993, Wkly Epidemiol. Rec. 70:81–85 (1995).
World Health Organization, World Health Organization vaccine-preventable diseases: Monitoring system 2007 report. World Health Organization, Geneva, 2008. Available at: http://www.who.int/immunization/documents/WHO_IVB_2007/en/index.html.
World Health Organization, Validation of neonatal tetanus elimination in Andhra Pradesh, India, Wkly Epidemiol. Rec. 79:292–297 (2004).
Fraser, D. W., Tetanus in the United States, 1900–1969: Analysis by cohorts, Am. J. Epidemiol. 96:306–312 (1972).
Heath, C. W., Zusman, J., and Sherman, I. L., Tetanus in the United States, 1950–1960, Am. J. Public Health 54:769–779 (1964).
Blake, P. A., and Feldman, R. A., Tetanus in the United States 1970–1971, J. Infect. Dis. 131:745–748 (1975).
Prevots, R., Sutter, R. W., Strebel, P. M., Cochi, S. L., and Hadler, S., Tetanus surveillance—United States, 1989–1990, Morb. Mortal. Wkly Rep. 41(SS8):1–9 (1992).
Izurieta, H. S., Sutter, R. W., Strebel, P. M., et al., Tetanus surveillance—United States, 1991–1994, Morb. Mortal. Wkly Rep. 46(SS-2):16–24 (1996).
Bardenheier, B., Prevots, D. R., Khetsuriani, N., and Wharton, M. Tetanus surveillance—United States, 1995–1997, Morb. Mortal. Wkly Rep. 47(SS-2):1–13 (1998).
Pascual, F. B., McGinley, E., Zanardi, L., et al., Tetanus surveillance—United States, 1998–2000, Morb. Mortal. Wkly Rep. 52(SS-3):1–8 (2003).
Srivastava, P., Brown, K., Chen, J., Kretsinger, K., and Roper, M. H. Trends in tetanus epidemiology in the United States, 1972–2001. Workshop 27; 39th National Immunization Conference, Washingon, DC. March 21–24, 2005. Available at: http://cdc.confex.com/cdc/nic2005/techprogram/paper_7813.htm.
Centers for Disease Control and Prevention, unpublished data for 2002–2005.
Hinman, A. R., Foster, S. O., and Wassilak, S. G. F., Neonatal tetanus: Potential for elimination in the USA and the world, Pediatr. Infect. Dis. J. 6:813–816 (1987).
Cherubin, C. E., Epidemiology of tetanus in narcotic addicts, NY State J. Med. 70:267–271 (1970).
Sun, K. O., Outbreak of tetanus among heroin addicts in Hong Kong, J. R. Soc. Med. 87:494–495 (1994).
Bytchenko, B., Geographical distribution of tetanus in the world, 1951–60, Bull. WHO 34:71–104 (1966).
Ball, K., Norboo, T., Gupta, U., and Shafi, S., Is tetanus rare at high altitudes? Trop. Doct. 24:78–80 (1994).
Long, A. P., and Sartwell, P. E., Tetanus in the US Army in World War II, Bull. US Army Med. Dep. 7:371–385 (1947).
Yen, L. M., Dao, L. M., Day, N. P. J., et al., Role of quinine in the high mortality of intramuscular injection tetanus, Lancet 344: 786–787 (1994).
Lowbury, E. J. L., and Lilly, H. A., Contamination of operating-theatre air with Cl. tetani, Br. Med. J. 2:1334–1336 (1958).
O’Malley, C. D., Smith, N., Braun, R., Prevots, D. R., Tetanus associated with body piercing [letter], Clin. Infect. Dis. 27:1343–1344 (1998).
Dyce, O., Bruno, J. R., Hong, D., et al., Tongue piercing… the new “rusty nail”? Head Neck 22:728–732 (2000).
Bauer, J. H., and Meyer, K. F., Human intestinal carriers of tetanus spores in California, J. Infect. Dis. 38:295–305 (1926).
Bennett, J., Ma, C., Traverso, H., et al., Neonatal tetanus associated with topical umbilical ghee: Covert role of cow dung, Int. J. Epidemiol. 28:1172–1175 (1999).
Rahman, S., The effect of traditional birth attendants and tetanus toxoid in reduction of neonatal mortality, J. Trop. Pediatr. 28:163– 165 (1982).
Berggren, G. G., Verly, A., Garnier, N., et al., Traditional midwives, tetanus immunization, and infant mortality in rural Haiti, Trop. Doct. 13:79–87 (1983).
Meegan, M. E., Conroy, R. M., Lengeny, S. O., Renhault, K., Nyangole, J., Effect on neonatal tetanus mortality after a culturally-based health promotion programme, Lancet 358:640–641 (2001).
Parashar, U. D., Bennett, J., Boring, J. R., and Hlady, W. G., Topical antimicrobials applied to the umbilical cord stump: A new intervention against neonatal tetanus, Int. J. Epidemiol. 27:904–908 (1998).
Bennett, J., Breen, C., Traverso, H., et al., Circumcision and neonatal tetanus: Disclosure of risk and its reduction by topical antibiotics, Int. J. Epidemiol. 28:263–266 (1999).
Einhorn, M. S., Granoff, D. M., Nahm, M. H., Quinn, A., and Shackelford, P. G., Concentrations of antibodies in paired maternal and infant sera: Relationship to IgG subclass, J. Pediatr. 111:783–788 (1987).
Bulloch, W. E., and Cramer, W., On a new factor in the mechanism of bacterial infection, Proc. R. Soc. London Ser. B 90:513–528 (1919).
Kryzhanovsky, G. N., Pathophysiology. In Veronesi, R. (ed.). Tetanus: Important New Concepts. Excerpta Medica, Amsterdam, pp. 109–182, 1981.
Abel, J. J., Firor, W. M., and Chalain, W., Researches on tetanus. IX. Further evidence to show that tetanus toxin is not carried to central nervous system by way of the axis cylinders of motor nerves, Bull. Johns Hopkins Hosp. 63:373–402 (1938).
Schwab, M. E., and Thoenen, H. Selective binding, uptake and retrograde transport of tetanus toxin by nerve terminals in the rat iris, J. Cell. Biol. 77:1–13 (1978).
Montecucco, C., How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci. 11:314–317 (1986).
Lalli, G., Bohnert, S., Deinhardt, K., Verastegui, C., and Schiavo, G., The journey of tetanus and botulinum neurotoxins in neurons, Trends Microbiol. 11:431–437 (2003).
Herreros, J., and Schiavo, G., Lipid microdomains are involved in neurospecific binding and internalisation of clostridial neurotoxins, Int. J. Med. Microbiol. 291:447–453 (2002).
Humeau, Y., Doussau, F., Grant, N., and Poulain, G., How botulinum and tetanus neurotoxin block neurotransmitter release, Biochemie 82:427–446 (2000).
Lindley-Jones, M., Lewis, D., and Southgate, J. L., Recurrent tetanus, Lancet. 363:2048 (2004).
Matzkin, H., and Regev, S., Naturally acquired immunity to tetanus toxin in an isolated community, Infect. Immun. 48:267–268 (1985).
Veronesi, R., Bizzini, B., Focaccia, R., et al., Naturally acquired antibodies to tetanus toxin in humans and animals from the Galapagos Islands, J. Infect. Dis. 147:308–311 (1983).
Sneath, P. A. T., Kerlake, E. G., and Sruby, F., Tetanus immunity: Resistance of guinea pigs to lethal spore doses induced by active and passive immunization, Am. J. Hyg. 25:464–476 (1937).
Looney, J. M., Edsall, G., Ipsen, J., and Chasen, W. H., Persistence of antitoxin levels after tetanus-toxoid inoculation in adults, and effect of a booster dose after various intervals, N. Engl. J. Med. 254:6–12 (1956).
Wolters, K. L., and Dehmel, H., Abschliessende Untersuchungen über die Tetanusprophylaxe durch active Immunisierung, Z. Hyg. 124:326–332 (1942).
Berger, S. A., Cherubin, L. E., Nelson, S., and Levine, L., Tetanus despite preexisting antitetanus antibody, J. Am. Med. Assoc. 240: 769–770 (1978).
Weinstein, L., Tetanus, N. Engl. J. Med. 289:1293–1296 (1973).
Bruce, D., Tetanus, J. Hyg. 19:1–32 (1920).
Roistacher, K., and Griffin, J. W., Local tetanus, Johns Hopkins Med. J. 149:84–88 (1981).
Wright, D. K., Lalloo, U. G., Nayiger, S., and Govender, P., Autonomous nervous system dysfunction in severe tetanus: Current perspectives, Crit. Care Med. 17:371–374 (1989).
Veronesi, R., and Focaccia, R., The clinical picture. In Veronesi, R. (ed.). Tetanus: Important New Concepts, Excerpta Medica, Amsterdam, pp. 459–463, 1981.
Smith, W. D., and Tobias, M. A., Tetany, tetanus or drug reaction? Br. J. Anaesth. 48:703–705 (1976).
Boyd, R. E., Brennan, P. T., Denj, J. F., Rochester, D. F., and Spyker, D. A., Strychnine poisoning, Am. J. Med. 74:507–512 (1983).
Centers for Disease Control and Prevention, National, state, and urban area vaccination coverage among children aged 19–35 months – United States, 2005, Morb. Mortal. Wkly Rep. 55:998–993 (2006).
Centers for Disease Control and Prevention, Vaccination coverage among children in Kindergarten – United States, 2006–2007 school year, Morb. Mortal. Wkly Rep. 56:819–821 (2007).
Committee on Trauma, American College of Surgeons, Prophylaxis against tetanus in wound management, Am. Coll. Surg. Bull. 69:22–23, 1984. Revised 1995. Available at: http://www.facs.org/trauma/publications/tetanus.pdf.
Smith, J. W. G., Laurence, D. R., and Evans, D. G., Prevention of tetanus in the wounded, Br. Med. J. 3:453–455 (1975).
Suri, J. C., and Rubbo, S. D., Immunization against tetanus, J. Hyg. 59:29–48 (1961).
Moynihan, N. H., Serum sickness and local reactions in tetanus prophylaxis: A study of 400 cases, Br. Med. J. 2:264–266 (1955).
Centers for Disease Control, Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphocytic virus type III/lymphadenopathy-associated virus infection, Morb. Mortal. Wkly Rep. 35:231–233 (1986).
Levine, L., McComb, J. A., Dwyer, R. C., and Latham, W. C., Active–passive tetanus immunization, N. Engl. J. Med. 274:186–190 (1966).
Halsey, N. A., and Galazka, A., The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age, Bull. WHO 63:1151–1169 (1985).
Simonsen, O., Badsberg, J. H., Kjeldsen, K., et al., The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination, Acta Pathol. Microbiol. Scand. 94:77–82 (1986).
Jones, F. G., and Moss, J. M., Studies on tetanus toxoid. I: The antitoxic titer of human subject following immunization with tetanus toxoid and tetanus alum precipitated toxoid, J. Immunol. 30:115–125 (1936).
Gottlieb, S., McLaughlin, F. X., Levine, L., et al., Long-term immunity to tetanus: A statistical evaluation and its clinical implications, Am. J. Public Health 54:961–971 (1964).
Mahoney, L. J., Aprile, M. A., and Moloney, P. J., Combined active–passive immunization against tetanus in man, Can. Med. Assoc. J. 96:1401–1404 (1967).
Galazka, A., Stability of Vaccines, Expanded Programme on Immunization, World Health Organization, Geneva, 1989, WHO/EPI/GEN/89. 8.
American Academy of Pediatrics. Tetanus (lockjaw). In Pickering, L. K., Baker, C. J., Long, S. S., and McMillan, J. A. (eds.). Red Book: Report of the Committee on Infectious Diseases (27th ed). American Academy of Pediatrics, Elk Grove Village, IL, pp. 648–653, 2006.
Centers for Disease Control and Prevention, Diphtheria, tetanus and pertussis. Recommendations for vaccine use and other preventive measures. Recommendations of Advisory Committee for Immunization Practices (ACIP), Morb. Mortal. Wkly. Rep. 40(RR10):1–28 (1991).
World Health Organization, Tetanus Vaccine: WHO position paper. Wkly Epidemiol. Rec. 81:198–208 (2006).
Barkin, R. M., Pichichero, M. E., Samuelson, J. S., and Barkin, S. Z., Pediatric diphtheria and tetanus toxoids vaccine: Clinical and immunologic response when administered as the primary series, J. Pediatr. 106:779–781 (1985).
Edwards, K. M., Meade, B. D., Decker, M. D., et al., Comparison of 13 acellular pertussis vaccines: Overview and serologic response, Pediatrics 96:548–557 (1995).
Bernbaum, J. C., Daft, A., Anolik, R., et al., Response of preterm infants to diphtheria-tetanus-pertussis immunizations, J Pediatr 107:184–188 (1985).
Solomonova, K., and Vizev, S., Secondary response to boostering by purified aluminum-hydroxide-adsorbed tetanus antitoxin in aging and in aged adults, Immunobiology 158:312–319 (1981).
Hainz, U., Jenewein, B., Asch, E., Pfeiffer, K. P., Berger, P., and Grubeck-Loebenstein, B., Insufficient protection for healthy elderly adults by tetanus and TBE vaccines, Vaccine 23:3232–3235(2005).
Chen, S. T., Edsall, G., Peel, M. M., and Sinnathuray, T. A., Timing of antenatal tetanus immunization for effective protection of the neonate, Bull. WHO 61:159–163 (1983).
Newell, K. W., Duenas Lehman, A., LeBlanc, D. R., and Garces Osorio, N., The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial, Bull. WHO 35:863–871 (1966).
Simonsen, O., Kjeldsen, K., and Heron, I., Immunity against tetanus and effect of revaccination 25–30 years after primary vaccination, Lancet 2:1240–1242 (1984).
Centers for Disease Control and Prevention, Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morb. Mortal. Wkly Rep. 55(No. RR-3):1–43 (2006).
Centers for Disease Control and Prevention, Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morb. Mortal. Wkly Rep. 55(No. RR-17):1–33 (2006).
Centers for Disease Control and Prevention, The National Health Interview Survey 1999: Coverage Levels of Adult Vaccines. Available at: http://www.cdc.gov/vaccines/stats-surv/downloads/general-99.pdf.
Jones, A. E., Melville-Smith, M., Watkins, J., Seagroatt, V., Rice, L., and Sheffield, F., Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines, Commun. Med. 7: 99–106 (1985).
Macko, M. B., Comparison of the morbidity of tetanus toxoid boosters with tetanus–diphtheria toxoid boosters, Ann. Emerg. Med. 14:33–35 (1985).
McComb, J.A., and Levine, L., Adult immunization. II. Dosage reduction as a solution to increasing reactions to tetanus toxoid, N. Engl. J. Med. 265:1152–1153 (1961).
White, W. G., Barnes, G. M., Barker, E., et al., Reactions to tetanus toxoid, J. Hyg. 71:283–297 (1973).
Levine, L., and Edsall, G., Tetanus toxoid: What determines reaction proneness? J. Infect. Dis. 144:376 (1981).
Sisk, C. W., and Lewis, C. E. Reactions to tetanus-diphtheria toxoid (adult), Arch. Environ. Health 11:34–36 (1965).
Vaccine Safety Committee, Institute of Medicine. In Kathleen, R. S., Cynthia, J. H., and Richard, B. J., Jr. (eds). Adverse Events Following Childhood Vaccines. Evidence Bearing on Causality, National Academy Press, Washington, DC, 1994.
Tuttle, J., Chen, R. T., Rantala, H., et al., The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States, Am. J. Public Health 87:2045–2048 (1997).
Centers for Disease Control and Prevention, unpublished data.
Jacobs, R. L., Lowe, R. S., and Lanier, B. Q., Adverse reactions to tetanus toxoid. J. Am. Med. Assoc. 247:40–42 (1982).
Kaiser, G. C., King, R. D., Lempe, R. E., and Ruster, M. H., Delayed recall of active tetanus immunization, J. Am. Med. Assoc. 178: 914–916 (1961).
Peebles, T. C., Levine, L., Eldred, M. L., and Edsall, G., Tetanus-toxoid emergency boosters: A reappraisal, N. Engl. J. Med. 280: 575–581 (1969).
Lindsey, D., Tetanus prophylaxis—do our guidelines assure protection? [editorial]. J. Trauma 24:1063–1064 (1984).
Johnson, D. M. Fatal tetanus after prophylaxis with human tetanus immune globulin [letter]. J. Am. Med. Assoc. 207:1519 (1969).
Brand, D. A., Acampora, D., Gottlieg, L., Glancy, K. E., and Frazier, W. H., Adequacy of antitetanus prophylaxis in six hospital emergency rooms, N. Engl. J. Med. 309:636–640 (1983).
Giangrosso, J., and Smith, R. K., Misuse of tetanus immunoprophylaxis in wound care, Ann. Emerg. Med. 14:573–579(1985).
Talan, D. A., Abrahamian, F. M., Moran, G. J., et al., Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds, Ann. Emerg. Med. 43:305–314 (2004).
Lowbury, E. J. L., Kidson, A., Lilly, H. A., Wilkins, M. D., and Jackson, O. M., Prophylaxis against tetanus in non-immune patients with wounds: The role of antibiotics and of human anti-tetanus globulin, J. Hyg. 80:267–274 (1978).
United Nations Children’s Fund, World Health Organization, and United Nations Population Fund. Maternal and Neonatal Tetanus Elimination by 2005: Strategies for Achieving and Maintaining Elimination, November 2000 (WHO/V&B/02.09). World Health Organization, Geneva, 2002. Available at http://www.who.int/vaccines-documents/DocsPDF02/www692.pdf.
World Health Organization, Maternal and Neonatal Tetanus (MNT) elimination: Available at: http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index4.html (accessed January 18, 2008).
Suggested Readings
Bleck, T. P., Tetanus: Pathophysiology, management, and prophylaxis, Dis. Mon. 37:545–603 (1991).
Borrow, R., Balmer, P., and Roper M. H., Immunological basis for immunization series; module 3: Tetanus update 2006. World Health Organization, Geneva, 2007. Available at: http://www.who.int/vaccines-documents/DocsPDF07/869.pdf.
Roper, M. H., Vandelaer, J. H., and Gasse, F. L., Material and neonatal tetanus, Lancet 370:1947–1959 (2007).
Simonsen, O., Vaccination against tetanus and diphtheria. Evaluation of immunity in the Danish population, guidelines for revaccination, and methods for control of vaccination programs, Dan. Med. Bull. 36:24–47 (1989).
Stratton, K. R., Howe, C. J., and Johnston, R. B. (eds.). Adverse Events Following Childhood Vaccines, Evidence Bearing on Causality. National Academy Press, Washington, DC, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wassilak, S.G.F., Kretsinger, K. (2009). Tetanus. In: Brachman, P., Abrutyn, E. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09843-2_38
Download citation
DOI: https://doi.org/10.1007/978-0-387-09843-2_38
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09842-5
Online ISBN: 978-0-387-09843-2
eBook Packages: MedicineMedicine (R0)